Medpace Holdings

MEDP · NASDAQ · USD

598,08 $Variation par rapport à la clôture précédente: −4,18 %Variation absolue: −26,10 $

Clôture · 1 octobre 2026

Profil de la société

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Diagnostics & Research
Siège
5375 Medpace Way, 45227, Cincinnati
Salariés
6 500
Cotation
MEDP · NASDAQ
Devise
USD
Site web
medpace.com